After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
Proper patient communication is the key to achieving good outcomes when administering botulinum toxin, according to a speaker ...
The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
In a new webinar, industry experts explore how innovative technology and direct patient communication are transforming medication adherence in the UK.